Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 235 for “"ALK+"”.

  1. Brigatinib overview: A next generation ALK inhibitor for advance ALK positive NSCLC

    … ασθενών με NSCLC φέρουν αναδιατάξεις στο γονίδιο ALK , εμφανίζουν κλινική ανταπόκριση στους ALK αναστολείς ενώ παρουσιάζουν συχνά ανθεκτικότητα σε θεραπεία με ανάλογους αναστολείς. Οι ALK αναστολείς που χορηγούνται πιο συχνά σε ασθενείς με ALK-θετικό NSCLC είναι το crizotinib, το ceritinib και το …

    athens Repository record for Brigatinib overview: A next generation ALK inhibitor for advance ALK positive NSCLC (opens in a new tab)

  2. Mechanistic insights into ALK inhibitor resistance in neuroblastoma

    Anaplastic lymphoma kinase (ALK) is a driving oncogene in neuroblastoma and mutated in 8% - 10% of neuroblastoma cases. Despite high-risk neuroblastoma patients being treated with an intensive multimodal therapy, up to 60% of these patients relapse and the 10-year overall survival rate for …

    fu-berlin Repository record for Mechanistic insights into ALK inhibitor resistance in neuroblastoma (opens in a new tab)

  3. Modelling RANBP2-ALK-rearranged Epithelioid Inflammatory Myofibroblastic Sarcoma

    … myofibroblastic tumour characterised by ALK staining that is perinuclear or cytoplasmic with perinuclear accentuation, CD30 expression and early relapse despite crizotinib treatment [1, 2]. This study aimed to generate and utilise models of eIMS to assess molecular-targeted therapeutic …

    unsw Repository record for Modelling RANBP2-ALK-rearranged Epithelioid Inflammatory Myofibroblastic Sarcoma (opens in a new tab)

  4. Deciphering and Targeting ALK- and ROS1-Driven Pediatric Gliomas

    … receptor tyrosine kinases (RTKs), such as ALK, ROS1, NTRK1/2/3, and MET. Despite a relatively favorable prognosis, the optimal treatment strategies for IHGs remain undefined, and the biological consequences of RTK fusions are still poorly understood. This thesis investigates five …

    zurich Restricted access

  5. Pathological interaction of ALK and GSK3α/β in Neuroblastoma

    … activation of anaplastic lymphoma kinase (ALK) activity but its role in NCC development or tumorigenesis is not well understood. ALK has been shown to be expressed in migrating NCC and inhibition leads to migration defects ex vivo. The aim of my thesis was to refine the role of ALK in NCCs …

    kings Repository record for Pathological interaction of ALK and GSK3α/β in Neuroblastoma (opens in a new tab) Embargoed until 2029-12-01

  6. ALK, MET und ROS1 Alterationen beim nicht-kleinzelligen Bronchialkarzinom

    Hintergrund ALK, MET und ROS1 sind prädiktive und prognostische Marker, die beim nicht-kleinzelligen Bronchialkarzinom (NSCLC) mehr und mehr an Bedeutung gewinnen. Während ALK zunehmend Einzug in die Routinediagnostik erhält, werden weiterhin geeignete Methoden zum Nachweis von MET und ROS1 …

    fu-berlin Repository record for ALK, MET und ROS1 Alterationen beim nicht-kleinzelligen Bronchialkarzinom (opens in a new tab)

  7. Το Lorlatinib ως στοχευμένη θεραπεία στον ALK-θετικό μη μικροκυτταρικό καρκίνο του πνεύμονα / Lorlatinib as a targeted therapy in ALK-positive non small cell lung cancer

    … λεμφώματος (Anaplastic Lymphoma Kinase, ALK). Ο καρκίνος του πνεύμονα αποτελεί μία από τις κύριες αιτίες θανάτου σε όλο τον κόσμο, με το μη μικροκυτταρικό καρκίνωμα πνεύμονα (Νon small cell lung cancer, NSCLC) να αντιπροσωπεύει την μεγαλύτερη πλειονότητα. Το Lorlatinib ως φάρμακο έχει …

    athens Repository record for Το Lorlatinib ως στοχευμένη θεραπεία στον ALK-θετικό μη μικροκυτταρικό καρκίνο του πνεύμονα / Lorlatinib as a targeted therapy in ALK-positive non small cell lung cancer (opens in a new tab)

  8. ALK-1 mutated skin tumors: a case report and literature review /

    Anaplastic lymphoma kinase (ALK)-mutated tumors of the skin represent a rare and heterogeneous group of mesenchymal neoplasms that present significant diagnostic challenges due to their overlapping morphology and immunophenotypic features. This thesis aims to provide a structured overview of their …

    vilnius Repository record for ALK-1 mutated skin tumors: a case report and literature review / (opens in a new tab)

  9. Multilevel Deregulation of Survival Mechanisms In Npm-Alk+ T-Cell Lymphoma

    The anaplastic lymphoma kinase (ALK) is a single chain transmembrane receptor tyrosine kinase that belongs to the insulin receptor superfamily. Other members of this superfamily include the insulin receptor (IR), type I insulin-like growth factor receptor (IGF-IR), and the leukocyte tyrosine …

    uthsc Repository record for Multilevel Deregulation of Survival Mechanisms In Npm-Alk+ T-Cell Lymphoma (opens in a new tab)

  10. A CRISPR/CAS9 toolbox for the generation of Npm-Alk translocations

    … shows an anaplastic lymphoma kinase positive (ALK+) status. The ALK expression is strongly associated with chromosomal translocations, of which the Nucleophosmin-Anaplastic lymphoma kinase (NPM-ALK) translocation and its expression of the NPM-ALK fusion protein is the most common one. Previous …

    freiburg-diss Repository record for A CRISPR/CAS9 toolbox for the generation of Npm-Alk translocations (opens in a new tab)

  11. Systematic review of ALK inhibitors for metastatic non-small cell lung cancer

    … του Πνεύμονα (NSCLC) συνιστά τη χρήση των ALK αναστολέων Crizotinib, Ceritinib, Alectinib, Brigatinib και Lorlatinib. Η συλλογή και ανάλυση επιστημονικών κλινικών στοιχείων είναι απαραίτητη για τη χρήση αυτών των νέων θεραπευτικών μεθόδων για τη βελτίωση της ογκολογικής υγειονομικής …

    athens Repository record for Systematic review of ALK inhibitors for metastatic non-small cell lung cancer (opens in a new tab)

  12. EGFR ir ALK genų mutacijų paplitimas nesmulkiųjų ląstelių plaučių vėžiu sergančių pacientų populiacijoje /

    … (EGFR) and the anaplastic lymphoma kinase gene (ALK). The frequency of mutations in these genes varies in different countries; therefore, this study aimed to investigate the prevalence of EGFR and ALK mutations in a population of Lithuanian patients with NSCLC and to compare the observed …

    vilnius Repository record for EGFR ir ALK genų mutacijų paplitimas nesmulkiųjų ląstelių plaučių vėžiu sergančių pacientų populiacijoje / (opens in a new tab)

  13. ‘Thick description’ of Graphic truths with ethno-graphy: a story of ALK- positive

    … of a cancer diagnosis. On receiving an ALK-positive cancer diagnosis, I turned to the internet for further information. While some of the content that is available online is accurate, it is often low-resolution, and in some instances, factually incorrect or misleading. The quality of …

    concordia Download PDF for ‘Thick description’ of Graphic truths with ethno-graphy: a story of ALK- positive (opens in a new tab)

  14. Análisis de los receptores Tirosina Quinasa AlK, RET y ROS en los Adenocarcinomas Nasosinusales

    … del gen de la quinasa del linfoma anaplásico (ALK), al igual que otras translocaciones producen activación de RET y ROS. Estos son receptores tirosina quinasa involucrados en rutas de señalización celular que regulan la proliferación celular. Dichas alteraciones se identifican en el 1-5% de los …

    oviedo Repository record for Análisis de los receptores Tirosina Quinasa AlK, RET y ROS en los Adenocarcinomas Nasosinusales (opens in a new tab)

Page 1 of 12